Neola Medical AB (publ) (NEOLA.ST)
- Previous Close
2.4100 - Open
2.4700 - Bid 2.4100 x --
- Ask 2.4600 x --
- Day's Range
2.4100 - 2.4700 - 52 Week Range
1.8700 - 3.7800 - Volume
29,309 - Avg. Volume
18,415 - Market Cap (intraday)
187.86M - Beta (5Y Monthly) 1.00
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1400 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
3.20
Neola Medical AB (publ), together with its subsidiary, Neola Medical, Inc., develops medical technology devices for non-invasive continuous monitoring of the lungs of preterm born infants in Sweden. It offers NEOLA, a neonatal intensive care medical device that enables continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume changes and oxygen gas concentration. The company was formerly known as GPX Medical AB and changed its name to Neola Medical AB (publ) in June 2022. Neola Medical AB (publ) was incorporated in 2016 and is headquartered in Lund, Sweden.
www.neolamedical.comRecent News: NEOLA.ST
View MorePerformance Overview: NEOLA.ST
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NEOLA.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NEOLA.ST
View MoreValuation Measures
Market Cap
187.86M
Enterprise Value
168.31M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
2.72
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-99.48%
Return on Assets (ttm)
-8.46%
Return on Equity (ttm)
-13.60%
Revenue (ttm)
10.12M
Net Income Avi to Common (ttm)
-10.06M
Diluted EPS (ttm)
-0.1400
Balance Sheet and Cash Flow
Total Cash (mrq)
19.55M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
2.12M